Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06FWC
|
||||
Former ID |
DAP000934
|
||||
Drug Name |
Fludiazepam
|
||||
Synonyms |
Erispan; Fludiazepamum; ID 540; Erispan (TN); Fludiazepam [INN:JAN]; Fludiazepamum [INN-Latin]; ID-540; Fludiazepam (JP15/INN); 2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-methyl-(9CI); 7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one; 7-Chloro-5-(2-fluorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 7-Chloro-5-(2-fluorophenyl)-1-methyl-1H-1,4-benzodiazepin-2(3H)-one; 7-Chloro-5-(o-Fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one; 7-chloro-5-(2-fluorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] | Approved | [550695] | ||
Therapeutic Class |
Antianxiety Agents
|
||||
Company |
Dainippon Sumitomo Pharma
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H12ClFN2O
|
||||
Canonical SMILES |
CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F
|
||||
InChI |
1S/C16H12ClFN2O/c1-20-14-7-6-10(17)8-12(14)16(19-9-15(20)21)11-4-2-3-5-13(11)18/h2-8H,9H2,1H3
|
||||
InChIKey |
ROYOYTLGDLIGBX-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 3900-31-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
5329903, 7848417, 8152143, 10521344, 15073015, 22395274, 24775726, 29222504, 46507563, 50068854, 57321758, 58106961, 75208789, 103174587, 104303311, 125536937, 129160840, 134338209, 134984752, 137005587, 160964811, 162946636, 179323228, 196104470, 198979290, 198993235, 221672960, 226520183, 241076737, 250109099
|
||||
ChEBI ID |
ChEBI:31618
|
||||
SuperDrug ATC ID |
N05BA17
|
||||
SuperDrug CAS ID |
cas=003900310
|
||||
Target and Pathway | |||||
Target(s) | Peripheral-type benzodiazepine receptor | Target Info | Agonist | [537701] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
HTLV-I infection | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.